The trial demonstrated pharmacokinetic equivalence to the US-licensed and EU-authorized reference product, ORENCIA®. KSHB002, a 125 mg/mL pre-filled syringe injection, was evaluated in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback